P43 FIB-4 is superior to APRI and identifies HCV patients with less significant fibrosis who could be managed in primary care
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , , , |
|---|---|
| Fformat: | Llyfr |
| Cyhoeddwyd: |
Elsevier,
2017-08-01T00:00:00Z.
|
| Pynciau: | |
| Mynediad Ar-lein: | Connect to this object online. |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_c8b2c86be46c45ef90b26b9b996e2bb1 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a J. O'Beirne |e author |
| 700 | 1 | 0 | |a J.D. Mitchell |e author |
| 700 | 1 | 0 | |a A. Sloss |e author |
| 700 | 1 | 0 | |a B. Kay |e author |
| 700 | 1 | 0 | |a S. Higgins |e author |
| 700 | 1 | 0 | |a C. Orme |e author |
| 700 | 1 | 0 | |a A. Azzam |e author |
| 245 | 0 | 0 | |a P43 FIB-4 is superior to APRI and identifies HCV patients with less significant fibrosis who could be managed in primary care |
| 260 | |b Elsevier, |c 2017-08-01T00:00:00Z. | ||
| 500 | |a 2055-6640 | ||
| 500 | |a 10.1016/S2055-6640(20)30784-6 | ||
| 546 | |a EN | ||
| 690 | |a Microbiology | ||
| 690 | |a QR1-502 | ||
| 690 | |a Public aspects of medicine | ||
| 690 | |a RA1-1270 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Journal of Virus Eradication, Vol 3, Iss , Pp 26- (2017) | |
| 787 | 0 | |n http://www.sciencedirect.com/science/article/pii/S2055664020307846 | |
| 787 | 0 | |n https://doaj.org/toc/2055-6640 | |
| 856 | 4 | 1 | |u https://doaj.org/article/c8b2c86be46c45ef90b26b9b996e2bb1 |z Connect to this object online. |